The effects of warm-water footbath on relieving fatigue and insomnia of the gynecologic cancer patients on chemotherapy.
BACKGROUND
Most patients experience fatigue during chemotherapy. Ignoring this fatigue can contribute to worsening overall health of patients and a slowed recovery process.


OBJECTIVE
We investigated the effectiveness of a warm-water footbath on relieving fatigue and insomnia problems in patients undergoing chemotherapy.


METHODS
This was a 2-group, longitudinal study design. Adults diagnosed with gynecologic cancer and receiving a 4-series platinum chemotherapy regimen were recruited and then followed up for 6 months. They completed fatigue and insomnia items on the 1st, 2nd, 4th, 7th, and 14th days after each scheduled chemotherapy. Participants in the experimental group soaked their feet in 41°C to 42°C warm water for 20 minutes every evening, starting from the eve of receiving the first chemotherapy, whereas participants in the comparison group did not do so.


RESULTS
: There were 25 and 18 participants in the comparison and experimental groups, respectively, who completed the study. Participants in the experimental group reported a significant reduction in fatigue and improvement in sleep quality from the second session of chemotherapy and continued to improve during the study period.


CONCLUSIONS
A warm-water footbath intervention resulted in reduced fatigue and insomnia symptoms for gynecologic cancer patients during chemotherapy.


CONCLUSIONS
A warm-water footbath is local moist heat application. It is noninvasive and easy to apply at home. The findings provide empirical support that a warm-water footbath relieves fatigue and insomnia problems of patients undergoing chemotherapy. It can be a nonpharmaceutical method to help patients overcome fatigue and sleep problems during chemotherapy.
Yang
Huei-Lin
HL
Taipei Veteran General Hospital, Taipei, Taiwan.
Chen
Xue-Ping
XP
Lee
Kwo-Chen
KC
Fang
Fuei-Fen
FF
Chao
Yann-Fen
YF
D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001494:Baths / Q000379:methods; D005221:Fatigue / Q000139:chemically induced / Q000628:therapy*; D005260:Female; D005528:Foot; D005833:Genital Neoplasms, Female / Q000150:complications* / Q000188:drug therapy; D006305:Health Status Indicators; D006358:Hot Temperature / Q000627:therapeutic use*; D006801:Humans; D006875:Hydrotherapy / Q000379:methods*; D008875:Middle Aged; D017671:Platinum Compounds / Q000009:adverse effects; D011446:Prospective Studies; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced / Q000628:therapy*; D014867:Water; D055815:Young Adult
D000970:Antineoplastic Agents; D017671:Platinum Compounds; D014867:Water